Figure 2
Figure 2. ApoA-I requires lipid to prevent VWF self-association under shear stress. Purified VWF (7 μg/mL) was added to LRA-treated plasma with 10 mM EDTA and sheared at 2400 rpm for 90 minutes at 37°C. The VWF remaining in solution after exposure to shear stress was expressed as a percentage of VWF solution in parallel samples not exposed to shear. (A) Purified VWF in LRA-treated plasma was sheared in the presence of increasing concentrations of HDL or ApoA-I. (B) Purified VWF in LRA-treated plasma was sheared in the presence of buffer (10 mM HEPES, 25 mM NaCl, 10 mM EDTA, pH 7.5), desalted serum-free medium (SFM), LRA-treated SFM, purified ApoA-I (500 μg/mL), and combinations of these reagents. (C) Purified VWF in LRA-treated plasma was sheared in the presence of boiled plasma proteins (500 μg/mL) before or after treatment with LRA. (D) SDS-gradient polyacrylamide gel electrophoresis (4% to 15%) and Gelcode blue stain (Thermo Scientific) of boiled plasma (15 μg protein) and boiled plasma after treatment with LRA (8 μg protein).

ApoA-I requires lipid to prevent VWF self-association under shear stress. Purified VWF (7 μg/mL) was added to LRA-treated plasma with 10 mM EDTA and sheared at 2400 rpm for 90 minutes at 37°C. The VWF remaining in solution after exposure to shear stress was expressed as a percentage of VWF solution in parallel samples not exposed to shear. (A) Purified VWF in LRA-treated plasma was sheared in the presence of increasing concentrations of HDL or ApoA-I. (B) Purified VWF in LRA-treated plasma was sheared in the presence of buffer (10 mM HEPES, 25 mM NaCl, 10 mM EDTA, pH 7.5), desalted serum-free medium (SFM), LRA-treated SFM, purified ApoA-I (500 μg/mL), and combinations of these reagents. (C) Purified VWF in LRA-treated plasma was sheared in the presence of boiled plasma proteins (500 μg/mL) before or after treatment with LRA. (D) SDS-gradient polyacrylamide gel electrophoresis (4% to 15%) and Gelcode blue stain (Thermo Scientific) of boiled plasma (15 μg protein) and boiled plasma after treatment with LRA (8 μg protein).

Close Modal

or Create an Account

Close Modal
Close Modal